InsidersTradesSigma
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (23 ops.)
Insider track record
Board DirectorDisclosed buys
24
Disclosed sells
23
T+90 hit rate
46%
T+90 mean return
-16.6%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Flynn James E, Director. Director active across 20 companies, notably Werewolf Therapeutics, Inc.. In total, 72 disclosures have been recorded. Split: 24 buys · 23 sells. Total volume traded: €164.9m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 27 June 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations72 total
370,075 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:0
370,074 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:1
353,249 shares@ US$0.9306100.0% of flowCommon StockSEC:0001193805-25-000258:0
40,596 shares@ US$17.455.4% of flowClass A Common StockSEC:0001193805-24-001348:0
1,000,000 shares@ US$97.7580.3% of flowClass A Common StockSEC:0001193805-24-001275:0
862,587 sharesCommon StockSEC:0001193805-24-001131:0
5,883,000 sharesCommon StockSEC:0001193805-24-000938:0
2,499 shares0Class A Common StockSEC:0001193805-24-000809:0
3,055,049 sharesCommon StockSEC:0001193805-24-000414:0
47,992 shares@ US$10.9213.7% of flowClass A Common StockSEC:0001193805-24-000360:0
4,495 shares@ US$11.031.3% of flowClass A Common StockSEC:0001193805-24-000360:1
94,567 shares@ US$10.9227.1% of flowClass A Common StockSEC:0001193805-24-000360:2
88,040 shares@ US$11.1325.7% of flowClass A Common StockSEC:0001193805-24-000360:3
114,906 shares@ US$10.7032.2% of flowClass A Common StockSEC:0001193805-24-000360:4
1,430,206 shares@ US$8.7448.9% of flowCommon StockSEC:0001193805-24-000245:0
Ideal exit: 12 Nov 2024 (T+270)
757,548 sharesCommon StockSEC:0001193805-24-000147:0
12,123 sharesClass A Common StockSEC:0001193805-23-001525:0
8,400 shares0Common StockSEC:0001193805-23-000870:0
24,757 shares@ US$0.2515.7% of flowCommon StockSEC:0001193805-22-001817:0
3,692 shares@ US$0.282.6% of flowCommon StockSEC:0001193805-22-001793:0
909 shares@ US$0.280.6% of flowCommon StockSEC:0001193805-22-001793:2
28,977 shares@ US$0.2719.8% of flowCommon StockSEC:0001193805-22-001793:3
28,977 shares@ US$0.2719.8% of flowCommon StockSEC:0001193805-22-001793:4
7,136 shares@ US$0.274.9% of flowCommon StockSEC:0001193805-22-001793:5
3,693 shares@ US$0.282.6% of flowCommon StockSEC:0001193805-22-001793:1
25 of 72 declarations
About Flynn James E
James E Flynn is an executive at Werewolf Therapeutics, Inc.
